ALL 22 CHAPTERS COVERED
TEST BANK
,Table of Contents
Chapter 1: Fundamentals of Microbiology ........................................................................ 5
Multiple Choice Questions ................................................................................................ 5
Clinical Case Studies ......................................................................................................... 9
True/False Questions ....................................................................................................... 12
Matching/Classification Questions ................................................................................... 13
Chapter 2: Laboratory Methods and Safety .................................................................... 16
Multiple Choice Questions .............................................................................................. 16
Clinical Case Studies ....................................................................................................... 20
True/False Questions ....................................................................................................... 22
Matching/Classification Questions ................................................................................... 23
Chapter 3: Prokaryotic Cell Structure and Function ...................................................... 26
Multiple Choice Questions .............................................................................................. 26
Clinical Case Studies ....................................................................................................... 30
True/False Questions ....................................................................................................... 32
Matching/Classification Questions ................................................................................... 33
Chapter 4: Eukaryotic Microorganisms........................................................................... 36
Multiple Choice Questions .............................................................................................. 36
Clinical Case Studies ....................................................................................................... 40
True/False Questions ....................................................................................................... 42
Matching/Classification Questions ................................................................................... 43
Chapter 5: Viruses and Prions .......................................................................................... 46
Multiple Choice Questions .............................................................................................. 46
Clinical Case Studies ....................................................................................................... 50
True/False Questions ....................................................................................................... 52
Matching/Classification Questions ................................................................................... 53
Chapter 6: Microbial Metabolism .................................................................................... 56
Multiple Choice Questions .............................................................................................. 56
Clinical Case Studies ....................................................................................................... 60
True/False Questions ....................................................................................................... 62
Matching/Classification Questions ................................................................................... 63
Chapter 7: Microbial Growth and Control ...................................................................... 66
Multiple Choice Questions .............................................................................................. 66
Clinical Case Studies ....................................................................................................... 70
True/False Questions ....................................................................................................... 72
Matching/Classification Questions ................................................................................... 73
,Chapter 8: Microbial Genetics and Genetic Engineering ................................................ 76
Multiple Choice Questions .............................................................................................. 76
Clinical Case Studies ....................................................................................................... 80
True/False Questions ....................................................................................................... 82
Matching/Classification Questions ................................................................................... 83
Chapter 9: Antimicrobial Chemotherapy ........................................................................ 86
Multiple Choice Questions .............................................................................................. 86
Clinical Case Studies ....................................................................................................... 90
True/False Questions ....................................................................................................... 92
Matching/Classification Questions ................................................................................... 93
Chapter 10: Physical and Chemical Control Methods .................................................... 96
Multiple Choice Questions .............................................................................................. 96
Clinical Case Studies ..................................................................................................... 100
True/False Questions ..................................................................................................... 102
Matching/Classification Questions ................................................................................. 103
Chapter 11: Host-Microbe Interactions ......................................................................... 106
Multiple Choice Questions ............................................................................................ 106
Clinical Case Studies ..................................................................................................... 110
True/False Questions ..................................................................................................... 112
Matching/Classification Questions ................................................................................. 113
Chapter 12: Innate Immunity ......................................................................................... 116
Multiple Choice Questions ............................................................................................ 116
Clinical Case Studies ..................................................................................................... 120
True/False Questions ..................................................................................................... 122
Matching/Classification Questions ................................................................................. 123
Chapter 13: Adaptive Immunity ..................................................................................... 126
Multiple Choice Questions ............................................................................................ 126
Clinical Case Studies ..................................................................................................... 129
True/False Questions ..................................................................................................... 132
Matching/Classification Questions ................................................................................. 132
Chapter 14: Immunization and Immune Disorders....................................................... 135
Multiple Choice Questions ............................................................................................ 135
Clinical Case Studies ..................................................................................................... 139
True/False Questions ..................................................................................................... 141
Matching/Classification Questions ................................................................................. 142
Chapter 15: Diagnostic Microbiology ............................................................................. 145
Multiple Choice Questions ............................................................................................ 145
Clinical Case Studies ..................................................................................................... 149
, True/False Questions ..................................................................................................... 151
Matching/Classification Questions ................................................................................. 152
Chapter 16: Skin and Eye Infections .............................................................................. 155
Multiple Choice Questions ............................................................................................ 155
Clinical Case Studies ..................................................................................................... 159
True/False Questions ..................................................................................................... 161
Matching/Classification Questions ................................................................................. 162
Chapter 17: Respiratory System Infections ................................................................... 165
Multiple Choice Questions ............................................................................................ 165
Clinical Case Studies ..................................................................................................... 169
True/False Questions ..................................................................................................... 171
Matching/Classification Questions ................................................................................. 172
Chapter 18: Gastrointestinal Infections ......................................................................... 175
Multiple Choice Questions ............................................................................................ 175
Clinical Case Studies ..................................................................................................... 179
True/False Questions ..................................................................................................... 181
Matching/Classification Questions ................................................................................. 182
Chapter 19: Genitourinary and Sexually Transmitted Infections ................................. 185
Multiple Choice Questions ............................................................................................ 185
Clinical Case Studies ..................................................................................................... 188
True/False Questions ..................................................................................................... 191
Matching/Classification Questions ................................................................................. 192
Chapter 20: Cardiovascular, Lymphatic, and Systemic Infections ............................... 195
Multiple Choice Questions ............................................................................................ 195
Clinical Case Studies ..................................................................................................... 199
True/False Questions ..................................................................................................... 201
Matching/Classification Questions ................................................................................. 202
Chapter 21: Nervous System Infections ......................................................................... 205
Multiple Choice Questions ............................................................................................ 205
Clinical Case Studies ..................................................................................................... 209
True/False Questions ..................................................................................................... 211
Matching/Classification Questions ................................................................................. 212
Chapter 22: One Health: Environmental and Zoonotic Infections ............................... 215
Multiple Choice Questions ............................................................................................ 215
Clinical Case Studies ..................................................................................................... 219
True/False Questions ..................................................................................................... 221
Matching/Classification Questions ................................................................................. 222
, Microbiology Fundamentals: A Clinical Approach - Test Bank
Chapter 1: Fundamentals of Microbiology
Multiple Choice Questions
MCQ1.Which of the following scientists is credited with disproving spontaneous
generation through his swan-neck flask experiments?
A. Robert Koch
B. Louis Pasteur
C. Antonie van Leeuwenhoek
D. Joseph Lister
Correct Answer: B
Rationale: Louis Pasteur's swan-neck flask experiments (1859) demonstrated that
microorganisms come from pre-existing cells in the air, not from spontaneous generation.
This established the germ theory of disease.
Learning Objective: Describe historical developments that led to the germ theory of
disease | Difficulty: Easy
MCQ2.According to the CDC's BSL classification system, which biosafety level is
required for work with agents that pose moderate risk and are associated with human
disease of varying severity?
A. BSL-1
B. BSL-2
C. BSL-3
D. BSL-4
Correct Answer: B
Rationale: BSL-2 is appropriate for work with indigenous moderate-risk agents
associated with human disease. Examples include Staphylococcus aureus and Salmonella
species. BSL-2 laboratories require limited access and use of biological safety cabinets
for procedures.
Learning Objective: Apply CDC biosafety level classifications to laboratory scenarios |
Difficulty: Medium
MCQ3.Which of the following is NOT one of Koch's postulates for establishing
causation of disease?
A. The microorganism must be present in every case of the disease
B. The microorganism must be isolated and grown in pure culture
C. The pure culture must cause disease when inoculated into a susceptible host
, Microbiology Fundamentals: A Clinical Approach - Test Bank
D. The microorganism must be visible without staining
Correct Answer: D
Rationale: Koch's postulates do not require visibility without staining. The four
postulates are: (1) organism present in all cases, (2) organism isolated in pure culture, (3)
pure culture causes disease in susceptible host, and (4) organism re-isolated from
experimentally infected host.
Learning Objective: Evaluate Koch's postulates and their limitations in modern
microbiology | Difficulty: Medium
MCQ4.A microbiologist needs to calculate the dilution factor when preparing a 1:1000
dilution from a stock culture. If 0.1 mL of stock is added to 9.9 mL of diluent, what is
the total dilution achieved?
A. 1:10
B. 1:100
C. 1:1000
D. 1:10,000
Correct Answer: B
Rationale: The dilution is calculated as volume transferred / total volume. Here, 0.1 mL /
(0.1 + 9.9) mL = 0.1/10 = 1/100. Therefore, the dilution is 1:100. To achieve 1:1000, this
would need to be diluted 1:10 again.
Learning Objective: Perform dilution calculations for microbiological procedures |
Difficulty: Medium
MCQ5.Which domain of life includes organisms that lack peptidoglycan in their cell
walls and often inhabit extreme environments?
A. Bacteria
B. Archaea
C. Eukarya
D. Protista
Correct Answer: B
Rationale: Archaea are prokaryotes that lack peptidoglycan in their cell walls and often
thrive in extreme environments (extremophiles). Their membrane lipids differ from
bacteria, and they represent a distinct domain of life based on rRNA sequencing.
Learning Objective: Compare the three domains of life and their characteristics |
Difficulty: Easy
, Microbiology Fundamentals: A Clinical Approach - Test Bank
MCQ6.In a clinical laboratory, which classification system is used for consistent
nomenclature of bacteria?
A. CDC classification
B. WHO nomenclature
C. International Code of Nomenclature of Prokaryotes (ICNP)
D. Clinical and Laboratory Standards Institute (CLSI) taxonomy
Correct Answer: C
Rationale: The International Code of Nomenclature of Prokaryotes (ICNP) governs the
scientific naming of bacteria and archaea. This ensures consistent nomenclature
worldwide, with names having Latin or Greek origins and following binomial
nomenclature rules.
Learning Objective: Apply proper taxonomic nomenclature for microorganisms |
Difficulty: Medium
MCQ7.Which of the following best describes the concept of "sterile technique" in
microbiology?
A. Using antibiotics to prevent contamination
B. Working with heat-sterilized equipment in a manner that prevents microbial
contamination
C. Wearing gloves and a lab coat
D. Using only autoclaved media
Correct Answer: B
Rationale: Sterile technique encompasses all practices that prevent contamination of
sterile materials, including proper handling of heat-sterilized equipment, working near a
flame, and maintaining aseptic conditions throughout procedures. It goes beyond just
using sterile equipment.
Learning Objective: Demonstrate understanding of aseptic technique principles |
Difficulty: Easy
MCQ8.A laboratory reports a microbial count of 2.5 x 10^5 CFU/mL. How is this
expressed in standard scientific notation?
A. 250,000 CFU/mL
B. 25,000 CFU/mL
C. 2,500,000 CFU/mL
D. 0.25 x 10^6 CFU/mL
Correct Answer: A
, Microbiology Fundamentals: A Clinical Approach - Test Bank
Rationale: 2.5 x 10^5 = 2.5 x 100,000 = 250,000 CFU/mL. This represents colony-
forming units per milliliter, a standard measure of viable bacterial concentration in
clinical and environmental samples.
Learning Objective: Interpret scientific notation in microbiological measurements |
Difficulty: Easy
MCQ9.Which historical figure first observed microorganisms using a single-lens
microscope?
A. Robert Hooke
B. Antonie van Leeuwenhoek
C. Louis Pasteur
D. Robert Koch
Correct Answer: B
Rationale: Antonie van Leeuwenhoek (1632-1723) constructed simple microscopes with a
single lens and was the first to observe and describe bacteria, protozoa, and other
microorganisms, which he called "animalcules."
Learning Objective: Identify key historical figures in microbiology and their contributions
| Difficulty: Easy
MCQ10.According to the CDC's 2024 guidelines, which PPE is required at minimum
for working with BSL-2 organisms?
A. Lab coat, gloves, and face shield
B. Lab coat and gloves only
C. Full protective suit with respirator
D. Gloves only
Correct Answer: B
Rationale: BSL-2 requires laboratory coats and gloves as minimum PPE. Face shields or
safety glasses are recommended for splash protection. Higher levels of PPE are required
for BSL-3 and BSL-4 work with more hazardous agents.
Learning Objective: Apply appropriate PPE selection for biosafety levels | Difficulty:
Medium
MCQ11.Which of the following is a limitation of Koch's postulates in modern infectious
disease research?
A. They cannot be applied to viral diseases
B. They require the ability to culture the organism, which is not possible for all pathogens
C. They only apply to bacterial infections
D. They require animal testing which is now prohibited
, Microbiology Fundamentals: A Clinical Approach - Test Bank
Correct Answer: B
Rationale: Many pathogens, including Mycobacterium leprae and Treponema pallidum,
cannot be cultured in artificial media. Additionally, some diseases have no animal model,
and ethical considerations limit human challenge studies. Molecular methods now
supplement Koch's postulates.
Learning Objective: Evaluate Koch's postulates and their limitations in modern
microbiology | Difficulty: Hard
MCQ12.If a microbiologist performs a 1:10 dilution followed by a 1:100 dilution, what
is the final dilution factor?
A. 1:10
B. 1:100
C. 1:1000
D. 1:10,000
Correct Answer: C
Rationale: Serial dilutions are multiplicative. A 1:10 dilution (10^-1) followed by a 1:100
dilution (10^-2) yields a final dilution of 10^-1 x 10^-2 = 10^-3 = 1:1000. This principle
is fundamental to quantitative microbiology.
Learning Objective: Calculate serial dilution factors for quantitative microbiology |
Difficulty: Medium
Clinical Case Studies
CASE1. CLINICAL SCENARIO
A clinical laboratory technician is processing sputum samples from patients with suspected
tuberculosis. The laboratory is equipped with BSL-2 facilities. The technician notices that the
BSL-3 facility is being renovated and unavailable.
What is the most appropriate action for the laboratory supervisor to take regarding
these specimens?
A. Process the specimens in the BSL-2 facility with standard precautions
B. Refer the specimens to a laboratory with BSL-3 capability
C. Have the technician wear double gloves and process the specimens
D. Heat-kill the specimens before processing
Correct Answer: B
Rationale: Mycobacterium tuberculosis requires BSL-3 containment due to its airborne
transmission route and significant public health risk. Processing in BSL-2 violates CDC
, Microbiology Fundamentals: A Clinical Approach - Test Bank
guidelines and puts laboratory workers at risk. Specimens must be referred to an
appropriate facility.
Learning Objective: Apply biosafety level requirements to clinical scenarios | Difficulty:
Hard
CASE2. CLINICAL SCENARIO
A research team is investigating a cluster of respiratory infections in a community. They
isolate a novel bacterium from patient samples. The organism grows on blood agar, is Gram-
positive, and appears to cause pneumonia in immunocompromised patients.
According to Koch's postulates, what is the next step the researchers should take to
establish causation?
A. Sequence the organism's genome
B. Inoculate the pure culture into a susceptible animal model
C. Test antibiotic susceptibility
D. Perform Gram staining on all patient samples
Correct Answer: B
Rationale: Koch's third postulate requires that the pure culture cause disease when
inoculated into a susceptible host. After isolating the organism in pure culture (postulate
2), the next step is to demonstrate pathogenicity in an appropriate animal model.
Learning Objective: Apply Koch's postulates to establish disease causation | Difficulty:
Medium
CASE3. CLINICAL SCENARIO
A water quality laboratory needs to determine the bacterial load in a river water sample. The
initial sample shows too many colonies to count on a direct plate. The technician prepares
serial dilutions of 1:10, 1:100, and 1:1000.
If the 1:100 dilution plate shows 250 colonies, what is the original bacterial
concentration in CFU/mL?
A. 2.5 x 10^3 CFU/mL
B. 2.5 x 10^4 CFU/mL
C. 2.5 x 10^5 CFU/mL
D. 2.5 x 10^6 CFU/mL
Correct Answer: C
Rationale: To calculate the original concentration, multiply the colony count by the
dilution factor: 250 colonies x 100 (dilution factor) = 25,000 = 2.5 x 10^4 CFU/mL. Wait
- correction: 250 x 100 = 25,000 = 2.5 x 10^4. The correct answer is B.
TEST BANK
,Table of Contents
Chapter 1: Fundamentals of Microbiology ........................................................................ 5
Multiple Choice Questions ................................................................................................ 5
Clinical Case Studies ......................................................................................................... 9
True/False Questions ....................................................................................................... 12
Matching/Classification Questions ................................................................................... 13
Chapter 2: Laboratory Methods and Safety .................................................................... 16
Multiple Choice Questions .............................................................................................. 16
Clinical Case Studies ....................................................................................................... 20
True/False Questions ....................................................................................................... 22
Matching/Classification Questions ................................................................................... 23
Chapter 3: Prokaryotic Cell Structure and Function ...................................................... 26
Multiple Choice Questions .............................................................................................. 26
Clinical Case Studies ....................................................................................................... 30
True/False Questions ....................................................................................................... 32
Matching/Classification Questions ................................................................................... 33
Chapter 4: Eukaryotic Microorganisms........................................................................... 36
Multiple Choice Questions .............................................................................................. 36
Clinical Case Studies ....................................................................................................... 40
True/False Questions ....................................................................................................... 42
Matching/Classification Questions ................................................................................... 43
Chapter 5: Viruses and Prions .......................................................................................... 46
Multiple Choice Questions .............................................................................................. 46
Clinical Case Studies ....................................................................................................... 50
True/False Questions ....................................................................................................... 52
Matching/Classification Questions ................................................................................... 53
Chapter 6: Microbial Metabolism .................................................................................... 56
Multiple Choice Questions .............................................................................................. 56
Clinical Case Studies ....................................................................................................... 60
True/False Questions ....................................................................................................... 62
Matching/Classification Questions ................................................................................... 63
Chapter 7: Microbial Growth and Control ...................................................................... 66
Multiple Choice Questions .............................................................................................. 66
Clinical Case Studies ....................................................................................................... 70
True/False Questions ....................................................................................................... 72
Matching/Classification Questions ................................................................................... 73
,Chapter 8: Microbial Genetics and Genetic Engineering ................................................ 76
Multiple Choice Questions .............................................................................................. 76
Clinical Case Studies ....................................................................................................... 80
True/False Questions ....................................................................................................... 82
Matching/Classification Questions ................................................................................... 83
Chapter 9: Antimicrobial Chemotherapy ........................................................................ 86
Multiple Choice Questions .............................................................................................. 86
Clinical Case Studies ....................................................................................................... 90
True/False Questions ....................................................................................................... 92
Matching/Classification Questions ................................................................................... 93
Chapter 10: Physical and Chemical Control Methods .................................................... 96
Multiple Choice Questions .............................................................................................. 96
Clinical Case Studies ..................................................................................................... 100
True/False Questions ..................................................................................................... 102
Matching/Classification Questions ................................................................................. 103
Chapter 11: Host-Microbe Interactions ......................................................................... 106
Multiple Choice Questions ............................................................................................ 106
Clinical Case Studies ..................................................................................................... 110
True/False Questions ..................................................................................................... 112
Matching/Classification Questions ................................................................................. 113
Chapter 12: Innate Immunity ......................................................................................... 116
Multiple Choice Questions ............................................................................................ 116
Clinical Case Studies ..................................................................................................... 120
True/False Questions ..................................................................................................... 122
Matching/Classification Questions ................................................................................. 123
Chapter 13: Adaptive Immunity ..................................................................................... 126
Multiple Choice Questions ............................................................................................ 126
Clinical Case Studies ..................................................................................................... 129
True/False Questions ..................................................................................................... 132
Matching/Classification Questions ................................................................................. 132
Chapter 14: Immunization and Immune Disorders....................................................... 135
Multiple Choice Questions ............................................................................................ 135
Clinical Case Studies ..................................................................................................... 139
True/False Questions ..................................................................................................... 141
Matching/Classification Questions ................................................................................. 142
Chapter 15: Diagnostic Microbiology ............................................................................. 145
Multiple Choice Questions ............................................................................................ 145
Clinical Case Studies ..................................................................................................... 149
, True/False Questions ..................................................................................................... 151
Matching/Classification Questions ................................................................................. 152
Chapter 16: Skin and Eye Infections .............................................................................. 155
Multiple Choice Questions ............................................................................................ 155
Clinical Case Studies ..................................................................................................... 159
True/False Questions ..................................................................................................... 161
Matching/Classification Questions ................................................................................. 162
Chapter 17: Respiratory System Infections ................................................................... 165
Multiple Choice Questions ............................................................................................ 165
Clinical Case Studies ..................................................................................................... 169
True/False Questions ..................................................................................................... 171
Matching/Classification Questions ................................................................................. 172
Chapter 18: Gastrointestinal Infections ......................................................................... 175
Multiple Choice Questions ............................................................................................ 175
Clinical Case Studies ..................................................................................................... 179
True/False Questions ..................................................................................................... 181
Matching/Classification Questions ................................................................................. 182
Chapter 19: Genitourinary and Sexually Transmitted Infections ................................. 185
Multiple Choice Questions ............................................................................................ 185
Clinical Case Studies ..................................................................................................... 188
True/False Questions ..................................................................................................... 191
Matching/Classification Questions ................................................................................. 192
Chapter 20: Cardiovascular, Lymphatic, and Systemic Infections ............................... 195
Multiple Choice Questions ............................................................................................ 195
Clinical Case Studies ..................................................................................................... 199
True/False Questions ..................................................................................................... 201
Matching/Classification Questions ................................................................................. 202
Chapter 21: Nervous System Infections ......................................................................... 205
Multiple Choice Questions ............................................................................................ 205
Clinical Case Studies ..................................................................................................... 209
True/False Questions ..................................................................................................... 211
Matching/Classification Questions ................................................................................. 212
Chapter 22: One Health: Environmental and Zoonotic Infections ............................... 215
Multiple Choice Questions ............................................................................................ 215
Clinical Case Studies ..................................................................................................... 219
True/False Questions ..................................................................................................... 221
Matching/Classification Questions ................................................................................. 222
, Microbiology Fundamentals: A Clinical Approach - Test Bank
Chapter 1: Fundamentals of Microbiology
Multiple Choice Questions
MCQ1.Which of the following scientists is credited with disproving spontaneous
generation through his swan-neck flask experiments?
A. Robert Koch
B. Louis Pasteur
C. Antonie van Leeuwenhoek
D. Joseph Lister
Correct Answer: B
Rationale: Louis Pasteur's swan-neck flask experiments (1859) demonstrated that
microorganisms come from pre-existing cells in the air, not from spontaneous generation.
This established the germ theory of disease.
Learning Objective: Describe historical developments that led to the germ theory of
disease | Difficulty: Easy
MCQ2.According to the CDC's BSL classification system, which biosafety level is
required for work with agents that pose moderate risk and are associated with human
disease of varying severity?
A. BSL-1
B. BSL-2
C. BSL-3
D. BSL-4
Correct Answer: B
Rationale: BSL-2 is appropriate for work with indigenous moderate-risk agents
associated with human disease. Examples include Staphylococcus aureus and Salmonella
species. BSL-2 laboratories require limited access and use of biological safety cabinets
for procedures.
Learning Objective: Apply CDC biosafety level classifications to laboratory scenarios |
Difficulty: Medium
MCQ3.Which of the following is NOT one of Koch's postulates for establishing
causation of disease?
A. The microorganism must be present in every case of the disease
B. The microorganism must be isolated and grown in pure culture
C. The pure culture must cause disease when inoculated into a susceptible host
, Microbiology Fundamentals: A Clinical Approach - Test Bank
D. The microorganism must be visible without staining
Correct Answer: D
Rationale: Koch's postulates do not require visibility without staining. The four
postulates are: (1) organism present in all cases, (2) organism isolated in pure culture, (3)
pure culture causes disease in susceptible host, and (4) organism re-isolated from
experimentally infected host.
Learning Objective: Evaluate Koch's postulates and their limitations in modern
microbiology | Difficulty: Medium
MCQ4.A microbiologist needs to calculate the dilution factor when preparing a 1:1000
dilution from a stock culture. If 0.1 mL of stock is added to 9.9 mL of diluent, what is
the total dilution achieved?
A. 1:10
B. 1:100
C. 1:1000
D. 1:10,000
Correct Answer: B
Rationale: The dilution is calculated as volume transferred / total volume. Here, 0.1 mL /
(0.1 + 9.9) mL = 0.1/10 = 1/100. Therefore, the dilution is 1:100. To achieve 1:1000, this
would need to be diluted 1:10 again.
Learning Objective: Perform dilution calculations for microbiological procedures |
Difficulty: Medium
MCQ5.Which domain of life includes organisms that lack peptidoglycan in their cell
walls and often inhabit extreme environments?
A. Bacteria
B. Archaea
C. Eukarya
D. Protista
Correct Answer: B
Rationale: Archaea are prokaryotes that lack peptidoglycan in their cell walls and often
thrive in extreme environments (extremophiles). Their membrane lipids differ from
bacteria, and they represent a distinct domain of life based on rRNA sequencing.
Learning Objective: Compare the three domains of life and their characteristics |
Difficulty: Easy
, Microbiology Fundamentals: A Clinical Approach - Test Bank
MCQ6.In a clinical laboratory, which classification system is used for consistent
nomenclature of bacteria?
A. CDC classification
B. WHO nomenclature
C. International Code of Nomenclature of Prokaryotes (ICNP)
D. Clinical and Laboratory Standards Institute (CLSI) taxonomy
Correct Answer: C
Rationale: The International Code of Nomenclature of Prokaryotes (ICNP) governs the
scientific naming of bacteria and archaea. This ensures consistent nomenclature
worldwide, with names having Latin or Greek origins and following binomial
nomenclature rules.
Learning Objective: Apply proper taxonomic nomenclature for microorganisms |
Difficulty: Medium
MCQ7.Which of the following best describes the concept of "sterile technique" in
microbiology?
A. Using antibiotics to prevent contamination
B. Working with heat-sterilized equipment in a manner that prevents microbial
contamination
C. Wearing gloves and a lab coat
D. Using only autoclaved media
Correct Answer: B
Rationale: Sterile technique encompasses all practices that prevent contamination of
sterile materials, including proper handling of heat-sterilized equipment, working near a
flame, and maintaining aseptic conditions throughout procedures. It goes beyond just
using sterile equipment.
Learning Objective: Demonstrate understanding of aseptic technique principles |
Difficulty: Easy
MCQ8.A laboratory reports a microbial count of 2.5 x 10^5 CFU/mL. How is this
expressed in standard scientific notation?
A. 250,000 CFU/mL
B. 25,000 CFU/mL
C. 2,500,000 CFU/mL
D. 0.25 x 10^6 CFU/mL
Correct Answer: A
, Microbiology Fundamentals: A Clinical Approach - Test Bank
Rationale: 2.5 x 10^5 = 2.5 x 100,000 = 250,000 CFU/mL. This represents colony-
forming units per milliliter, a standard measure of viable bacterial concentration in
clinical and environmental samples.
Learning Objective: Interpret scientific notation in microbiological measurements |
Difficulty: Easy
MCQ9.Which historical figure first observed microorganisms using a single-lens
microscope?
A. Robert Hooke
B. Antonie van Leeuwenhoek
C. Louis Pasteur
D. Robert Koch
Correct Answer: B
Rationale: Antonie van Leeuwenhoek (1632-1723) constructed simple microscopes with a
single lens and was the first to observe and describe bacteria, protozoa, and other
microorganisms, which he called "animalcules."
Learning Objective: Identify key historical figures in microbiology and their contributions
| Difficulty: Easy
MCQ10.According to the CDC's 2024 guidelines, which PPE is required at minimum
for working with BSL-2 organisms?
A. Lab coat, gloves, and face shield
B. Lab coat and gloves only
C. Full protective suit with respirator
D. Gloves only
Correct Answer: B
Rationale: BSL-2 requires laboratory coats and gloves as minimum PPE. Face shields or
safety glasses are recommended for splash protection. Higher levels of PPE are required
for BSL-3 and BSL-4 work with more hazardous agents.
Learning Objective: Apply appropriate PPE selection for biosafety levels | Difficulty:
Medium
MCQ11.Which of the following is a limitation of Koch's postulates in modern infectious
disease research?
A. They cannot be applied to viral diseases
B. They require the ability to culture the organism, which is not possible for all pathogens
C. They only apply to bacterial infections
D. They require animal testing which is now prohibited
, Microbiology Fundamentals: A Clinical Approach - Test Bank
Correct Answer: B
Rationale: Many pathogens, including Mycobacterium leprae and Treponema pallidum,
cannot be cultured in artificial media. Additionally, some diseases have no animal model,
and ethical considerations limit human challenge studies. Molecular methods now
supplement Koch's postulates.
Learning Objective: Evaluate Koch's postulates and their limitations in modern
microbiology | Difficulty: Hard
MCQ12.If a microbiologist performs a 1:10 dilution followed by a 1:100 dilution, what
is the final dilution factor?
A. 1:10
B. 1:100
C. 1:1000
D. 1:10,000
Correct Answer: C
Rationale: Serial dilutions are multiplicative. A 1:10 dilution (10^-1) followed by a 1:100
dilution (10^-2) yields a final dilution of 10^-1 x 10^-2 = 10^-3 = 1:1000. This principle
is fundamental to quantitative microbiology.
Learning Objective: Calculate serial dilution factors for quantitative microbiology |
Difficulty: Medium
Clinical Case Studies
CASE1. CLINICAL SCENARIO
A clinical laboratory technician is processing sputum samples from patients with suspected
tuberculosis. The laboratory is equipped with BSL-2 facilities. The technician notices that the
BSL-3 facility is being renovated and unavailable.
What is the most appropriate action for the laboratory supervisor to take regarding
these specimens?
A. Process the specimens in the BSL-2 facility with standard precautions
B. Refer the specimens to a laboratory with BSL-3 capability
C. Have the technician wear double gloves and process the specimens
D. Heat-kill the specimens before processing
Correct Answer: B
Rationale: Mycobacterium tuberculosis requires BSL-3 containment due to its airborne
transmission route and significant public health risk. Processing in BSL-2 violates CDC
, Microbiology Fundamentals: A Clinical Approach - Test Bank
guidelines and puts laboratory workers at risk. Specimens must be referred to an
appropriate facility.
Learning Objective: Apply biosafety level requirements to clinical scenarios | Difficulty:
Hard
CASE2. CLINICAL SCENARIO
A research team is investigating a cluster of respiratory infections in a community. They
isolate a novel bacterium from patient samples. The organism grows on blood agar, is Gram-
positive, and appears to cause pneumonia in immunocompromised patients.
According to Koch's postulates, what is the next step the researchers should take to
establish causation?
A. Sequence the organism's genome
B. Inoculate the pure culture into a susceptible animal model
C. Test antibiotic susceptibility
D. Perform Gram staining on all patient samples
Correct Answer: B
Rationale: Koch's third postulate requires that the pure culture cause disease when
inoculated into a susceptible host. After isolating the organism in pure culture (postulate
2), the next step is to demonstrate pathogenicity in an appropriate animal model.
Learning Objective: Apply Koch's postulates to establish disease causation | Difficulty:
Medium
CASE3. CLINICAL SCENARIO
A water quality laboratory needs to determine the bacterial load in a river water sample. The
initial sample shows too many colonies to count on a direct plate. The technician prepares
serial dilutions of 1:10, 1:100, and 1:1000.
If the 1:100 dilution plate shows 250 colonies, what is the original bacterial
concentration in CFU/mL?
A. 2.5 x 10^3 CFU/mL
B. 2.5 x 10^4 CFU/mL
C. 2.5 x 10^5 CFU/mL
D. 2.5 x 10^6 CFU/mL
Correct Answer: C
Rationale: To calculate the original concentration, multiply the colony count by the
dilution factor: 250 colonies x 100 (dilution factor) = 25,000 = 2.5 x 10^4 CFU/mL. Wait
- correction: 250 x 100 = 25,000 = 2.5 x 10^4. The correct answer is B.
